Lone Pine Capital 13F: Adds $88M to Tenet Healthcare (THC) Stake

Lone Pine Capital has increased its investment in Tenet Healthcare Corporation (NYSE:THC) by 26.4%, according to the latest Form 13F filing with the SEC. The hedge fund added 471,391 shares, bringing its total holdings to 2,258,717 shares, valued at approximately $394.5 million as of the reporting period.

What Changed in Lone Pine Capital's Tenet Healthcare Position

Lone Pine Capital boosted its stake in Tenet Healthcare from 1,787,326 shares to 2,258,717 shares, an increase of 471,391 shares. This represents a 26.4% increase in their position, with the total value of the shares now standing at about $394.5 million.

Other Institutional Activity in Tenet Healthcare

In addition to Lone Pine Capital's move, other major funds have also adjusted their positions in Tenet Healthcare. BlackRock, Inc. grew its holdings by 168,752 shares, ending with 8,704,644 shares worth about $1.64 billion. FMR LLC added 134,397 shares, bringing its total to 7,776,579 shares valued at $1.47 billion. Price T Rowe Associates Inc /MD/ increased its position by 28,392 shares, now holding 7,518,742 shares valued at approximately $1.42 billion. Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both reported new positions, with 4,316,887 shares and 3,911,408 shares, respectively.

Tenet Healthcare Corporation Stock Down 28.6%

Shares of Tenet Healthcare Corporation (NYSE:THC) are trading near $174.66. The company has a market capitalization of $15.04 billion and a P/E ratio of 9.08. Its beta is 1.278, indicating moderate volatility relative to the market. Over the past 52 weeks, the stock has ranged from a low of $146.60 to a high of $247.21. The 50-day moving average is $184.09, while the 200-day moving average is $198.90.

Recent Earnings

Tenet Healthcare reported revenue of $21.45 billion, with a growth rate of 2.8%. The company's net margin stands at 7.94%, and its return on equity is 30.29%. The next earnings report is expected on July 21, 2026.

Insider Buying and Selling at Tenet Healthcare Corporation

Recent insider activity at Tenet Healthcare includes a sale by Robert Kerrey of 5,638 shares on May 28, 2026. On May 27, 2026, several insiders, including Richard Fisher and Cecil Haney, each acquired 1,188 shares.

Analysts Set New Price Targets

Analysts have maintained their ratings on Tenet Healthcare, with Barclays maintaining a 'buy' rating and setting a price target of $238 on May 5, 2026. Baird maintained a 'hold' rating with a $210 target, while Stephens & Co. set a 'buy' rating with a $260 target. The consensus among analysts is a 'strong buy', with an average target price of $243.62.

About Tenet Healthcare Corporation

Tenet Healthcare Corporation is a diversified healthcare services company headquartered in Dallas, Texas. The company operates through two main segments: Hospital Operations and Services, and Ambulatory Care. It manages general hospitals offering a range of services, including acute care, specialty care, and outpatient services. With approximately 77,000 employees, Tenet provides comprehensive healthcare services across the United States under the leadership of CEO Dr. Saumya Sutaria.

Bottom Line

Lone Pine Capital's recent increase in its stake in Tenet Healthcare reflects confidence in the company's prospects. As one of the major players in the healthcare sector, Tenet's stock performance and institutional interest are closely watched by investors. Remember, 13F filings are backward-looking and may not represent the current position of the fund.